Catalyst Wire Dossier Catalyst Wire Dossier

pimecrolimus cream (Elidel)

pimecrolimus · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pimecrolimus cream (Elidel), covering 2017-03-15 to 2017-03-15. Get the full timeline:

Most recent: Clinical Trial Update: 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX [Phase 2]

See pricing